Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma

These findings demonstrate that ERAP1 inhibition combined with HDACi entinostat treatment and PD-1 blockade remodels the immune landscape of a non-immunogenic tumor such as NB, making it responsive to checkpoint immunotherapy.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2024-10-22
DOI
https://doi.org/10.1186/s13046-024-03180-y
Citations
15
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
5.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma

Kamila Król, Valentina Doria, Doriana Fruci, Valeria Lucarini et al.
15 citations
Journal of Experimental & Clinical Cancer Research
Neuroblastoma Research and Treatments
5.54
article

Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma

Kamila Król, Valentina Doria, Doriana Fruci, Valeria Lucarini, Roberto Giovannoni, Patrizia Tempora, Silvia D’Amico, Kirti Pandey, Franco Locatelli, Marco Pezzullo, Gabriele Volpe, Cristiano De Stefanis, Maria Antonietta De Ioris, Ombretta Melaiu, Verena Damiani, Ezio Giorda, Shanzou Chung, Marco Scarsella, Anthony W. Purcell, Paula Gragera, Lorenzo De Angelis, Valentina Scaldaferri
article en
15 citations

Abstract

These findings demonstrate that ERAP1 inhibition combined with HDACi entinostat treatment and PD-1 blockade remodels the immune landscape of a non-immunogenic tumor such as NB, making it responsive to checkpoint immunotherapy.

Journal of Experimental & Clinical Cancer ResearchVol. 43(1)
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Rome Tor Vergata (IT), Australian Regenerative Medicine Institute (AU), Polo d’Innovazione di Genomica (IT), Bambino Gesù Children's Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Monash University (AU)
Institut Necker-Enfants Malades, Australian Government, European Commission, Ministero della Salute, Fondazione Umberto Veronesi, Associazione Italiana per la Ricerca sul Cancro, Horizon 2020 Framework Programme, Medical Research Council, National Health and Medical Research Council, H2020 Marie Skłodowska-Curie Actions
Good health and well-being
Openalex Percentile: Top 3%
Neuroblastoma Research and Treatments
5.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.